TLE3 Antibody (CL3573) [Janelia Fluor® 669]
Novus Biologicals, part of Bio-Techne | Catalog # NBP3-43936JF669
Conjugate
Catalog #
Key Product Details
Species Reactivity
Human
Applications
Immunohistochemistry-Paraffin, Immunocytochemistry/ Immunofluorescence
Label
Janelia Fluor 669
Antibody Source
Monoclonal Mouse IgG1 Clone # CL3573
Concentration
Concentrations vary lot to lot. See vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
This antibody was generated using a recombinant protein sequence of Q04726, with the exact immunogen sequence remaining proprietary.
Clonality
Monoclonal
Host
Mouse
Isotype
IgG1
Applications for TLE3 Antibody (CL3573) [Janelia Fluor® 669]
Application
Recommended Usage
Immunocytochemistry/ Immunofluorescence
Optimal dilutions of this antibody should be experimentally determined.
Immunohistochemistry-Paraffin
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A purified
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Concentrations vary lot to lot. See vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: TLE3
Long Name
Transducin-like Enhancer of Split 3
Alternate Names
ESG3, Grg3
Gene Symbol
TLE3
Additional TLE3 Products
Product Documents for TLE3 Antibody (CL3573) [Janelia Fluor® 669]
Product Specific Notices for TLE3 Antibody (CL3573) [Janelia Fluor® 669]
Sold under license from the Howard Hughes Medical Institute, Janelia Research Campus.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...